Junshi’s Toripalimab Receives the NMPA’s Approval as 1L Treatment for Locally Recurrent or Metastatic Nasopharyngeal Carcinoma
Shots: The sNDA is based on the P-III (JUPITER-02) study to evaluate toripalimab +...
Merck and Eisai’s Keytruda (pembrolizumab) + Lenvima (lenvatinib) Receive EC’s Approval as 1L Treatment of Advanced Renal Cell Carcinoma
Shots: The approval is based on the P-III (CLEAR/KEYNOTE-581) study to evaluate Ke...
BMS Reports the US FDA Acceptance of NDA for Deucravacitinib to Treat Plaque Psoriasis
Shots: The US FDA has accepted the NDA & EMA has validated the MAA for deucrav...
Qiagen and DiaSorin’s QuantiFERON-TB Gold Plus Assay Receives the US FDA’s Approval for the Treatment of Latent Tuberculosis Infection
Shots: The US FDA has approved the LIAISON QuantiFERON-TB Gold Plus assay for use...
Kintor Pharma Receives NMPA’s IND Clearance for KX-826 to Treat Male Androgenetic Alopecia (AGA)
Shots: The NMPA has cleared an IND application for a P-III study to evaluate the e...
